We studied changes in the bone tissue in patients with diffuse large B-cell lymphoma at the onset of the disease (N=41; before chemotherapy) and 5-16 years after the end of treatment (N=47). Osteodensitometry, biochemical markers of osteoporosis in the blood and urine, and gene expression in multipotent mesenchymal stromal cells were analyzed. In multipotent mesenchymal stromal cells of all patients, the expression of genes associated with bone and cartilage differentiation (FGF2, FGFR1, FGFR2, BGLAP, SPP1, TGFB1, and SOX9) was changed. In primary patients, the ratio of deoxypyridinoline/creatinine in the urine and blood level of β-cross-laps were increased, while plasma concentration of vitamin D was reduced, which indicates activation of bone resorption. No differences between the groups were revealed by osteodensitometry. No direct relationship between changes in gene expression in multipotent mesenchymal stromal cells and osteoporosis markers was found. The presence of a tumor in the body affects the bone marrow stroma, but achievement of remission and compensatory mechanisms provide age-appropriate condition of the bone tissue.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Novikov VE, Rykova MP, Antropova EN, Berendeeva TA, Kalinin SA, Vassilieva GY, Ponomarev SA. Bone Mineral Density and Molecular Genetic Markers of Bone Remodeling in Blood of Cosmonauts after Long-term Missions on Board the International Space Station. Human Physiol. 2017;43(6):686-692.
Adachi JD, Olszynski WP, Hanley DA, Hodsman AB, Kendler DL, Siminoski KG, Brown J, Cowden EA, Goltzman D, Ioannidis G, Josse RG, Ste-Marie LG, Tenenhouse AM, Davison KS, Blocka KL, Pollock AP, Sibley J. Management of corticosteroid-induced osteoporosis.. Semin. Arthritis Rheum. 2000;29(4):228-251. doi: https://doi.org/10.1016/s0049-0172(00)80011-6
Camacho PM, Petak SM, Binkley N, Clarke BL, Harris ST, Hurley DL, Kleerekoper M, Lewiecki EM, Miller PD, Narula HS, Pessah-Pollack R, Tangpricha V, Wimalawansa SJ, Watts NB. American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis - 2016. Endocr. Pract. 2016;22(Suppl. 4):1-42. doi: https://doi.org/10.4158/EP161435.GL
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006 Vol. 8(4):315-317.
Fastova EA, Magomedova AU, Petinati NA, Sats NV, Kapranov NM, Davydova YO, Drize NI, Kravchenko SK, Savchenko VG. Bone Marrow Multipotent Mesenchymal Stromal Cells in Patients with Diffuse Large B-Cell Lymphoma. Bull. Exp. Biol. Med. 2019;167(1):150-153. doi: https://doi.org/10.1007/s10517-019-04480-6
Lymperi S, Horwood N, Marley S, Gordon MY, Cope AP, Dazzi F. Strontium can increase some osteoblasts without increasing hematopoietic stem cells. Blood. 2008;111(3):1173-1181.
Ohyashiki JH, Umezu T, Ohyashiki K. Extracellular vesicle-mediated cell-cell communication in haematological neoplasms. Philos. Trans. R Soc. Lond. B Biol. Sci. 2018;373. pii: 20160484. doi: https://doi.org/10.1098/rstb.2016.0484
Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 2008;3(6):1101-1108.
Schroeder T, Geyh S, Germing U, Haas R. Mesenchymal stromal cells in myeloid malignancies. Blood Res. 2016;51(4):225-232. doi: https://doi.org/10.5045/br.2016.51.4.225
Sharma M, Ross C, Srivastava S. Ally to adversary: mesenchymal stem cells and their transformation in leukaemia. Cancer Cell Int. 2019;19. 139. doi: https://doi.org/10.1186/s12935-019-0855-5
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. NLM Catalog. Lyon, 2017.
Weilbaecher KN, Guise TA, McCauley LK. Cancer to bone: a fatal attraction. Nat. Rev. Cancer. 2011;11(6):411-425. doi: https://doi.org/10.1038/nrc3055
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 169, No. 5, pp. 608-613, May, 2020
Rights and permissions
About this article
Cite this article
Fastova, E.A., Magomedova, A.U., Kravchenko, S.K. et al. Analysis of Bone Tissue Condition in Patients with Diffuse Large B-Cell Lymphoma without Bone Marrow Involvement. Bull Exp Biol Med 169, 677–682 (2020). https://doi.org/10.1007/s10517-020-04953-z
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-020-04953-z